Back
Milestone Pharmaceuticals, Inc. Stock Predictions
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
41
MIST
Milestone Pharmaceuticals, Inc.
Last Price:
$2.04
Seasonality Move:
-29.13%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Milestone Pharmaceuticals, Inc. Stock Forecast
-
Is Milestone Pharmaceuticals, Inc. Stock Undervalued?The current Milestone Pharmaceuticals, Inc. [MIST] share price is $2.05. The Score for MIST is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Milestone Pharmaceuticals, Inc. Stock Go Up Next Year?
Data Unavailable
Milestone Pharmaceuticals, Inc. Stock Rating
Data Unavailable
Milestone Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Canada
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
milestonepharma.com
52-Week Data
52-Week High:
3.06
52-Week Low:
0.63
Prediction Charts
Market Cap:
174.6M
Price in USD:
2.05
Volume:
2.6M
Beta:
1.83
Technical Analysis
SMA50:
2.21
SMA100:
2.07
SMA200:
1.77
52-Wk Change:
4.59%
Stock Predictions
-
Is Milestone Pharmaceuticals, Inc. stock public?Yes, Milestone Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Milestone Pharmaceuticals, Inc. stock quote today?The Milestone Pharmaceuticals, Inc. stock price is 2.05 USD today.
-
How to buy Milestone Pharmaceuticals, Inc. stock online?You can buy Milestone Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-26 | 2.05 | 2.08 | 2.14 | 1.98 |
| Dec-29 | 2.06 | 2.04 | 2.09 | 2.02 |
| Dec-30 | 2.03 | 1.96 | 2.08 | 1.96 |
| Dec-31 | 1.97 | 2.02 | 2.05 | 1.95 |
| Jan-5 | 2.05 | 2.02 | 2.09 | 1.98 |
| Jan-6 | 2.04 | 2.05 | 2.10 | 2.02 |
| Jan-7 | 2.05 | 2.15 | 2.25 | 2.03 |
| Jan-8 | 2.15 | 2.19 | 2.27 | 2.13 |
| Jan-9 | 2.18 | 2.04 | 2.19 | 1.98 |
| Jan-12 | 2.02 | 1.96 | 2.03 | 1.90 |
| Jan-13 | 1.98 | 1.93 | 2.01 | 1.91 |
| Jan-14 | 1.92 | 2.03 | 2.05 | 1.87 |
| Jan-15 | 2.03 | 2.03 | 2.13 | 2.02 |
| Jan-16 | 2.04 | 2.05 | 2.11 | 1.98 |
Milestone Pharmaceuticals, Inc. Earnings
Data Unavailable
Milestone Pharmaceuticals, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.31 per share.
* Milestone Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.